Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.20 (-0.12%) Nasdaq
17,732.60 -126.08 (-0.71%) Bitcoin USD
61,530.15 +635.21 (+1.04%) CMC Crypto 200
1,277.19 -6.63 (-0.52%)
SSYS Jan 2025 22.500 call
| Previous close | 0.0500 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 22.50 |
| Expiry date | 2025-01-17 |
| Day's range | 0.0500 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 149 |
ZacksStratasys (SSYS) Down 7% Since Last Earnings Report: Can It Rebound?
Stratasys (SSYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksStratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
Stratasys (SSYS) and Ricoh co-sponsor a clinical study comparing the efficacy of 3D-printed models to traditional CT or MRI scanning for bone tumor excision planning.
Business WireFirst Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal
EDEN PRAIRIE, Minn. & REHOVOT, Israel & EXTON, Pa., June 26, 2024--Stratasys Ltd. (NASDAQ: SSYS) and Ricoh USA, Inc. today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology. The study will assess the efficacy of patient-specific 3D printed anatomical models for preoperative planning and tumor excision in comparison to the current standard of care, which relies solely on CT or MRI imaging.
